Hélène Blons et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 10(8), 2594-2599 (2004-04-23)
Treatment of head and neck cancer often associates different therapeutic modalities, including surgery, radiotherapy, and chemotherapy. In an attempt to optimize therapeutics, the identification of molecular markers linked to response to chemotherapy remains important. Recently, the involvement of metalloproteinases in